Long-term inhibition of hepatitis B virus in transgenic mice by double-stranded adeno-associated virus 8-delivered short hairpin RNA. (Q40240165)

18 September 2017

Long-term inhibition of hepatitis B virus in transgenic mice by double-stranded adeno-associated virus 8-delivered short hairpin RNA. (English)

1 reference

18 September 2017

1 reference

Chen CC

1

1 reference

18 September 2017

Ko TM

2

1 reference

18 September 2017

Ma HI

3

1 reference

18 September 2017

Wu HL

4

1 reference

18 September 2017

Xiao X

5

1 reference

18 September 2017

Li J

6

1 reference

18 September 2017

Chang CM

7

1 reference

18 September 2017

Wu PY

8

1 reference

18 September 2017

Chen CH

9

1 reference

18 September 2017

Han JM

10

1 reference

18 September 2017

Yu CP

11

1 reference

18 September 2017

Jeng KS

12

1 reference

18 September 2017

Hu CP

13

1 reference

18 September 2017

Tao MH

14

1 reference

18 September 2017

24 August 2006

1 reference

18 September 2017

1 reference

18 September 2017

14

1 reference

18 September 2017

11-19

1 reference

18 September 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302846

18 September 2017

0 references

cites work

Hepatitis B virus infection--natural history and clinical consequences

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302846

Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302846

Lamivudine for patients with chronic hepatitis B and advanced liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302846

Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302846

Interferon alpha treatment and retreatment of hepatitis B e antigen-negative chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302846

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302846

Gene silencing as an adaptive defence against viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302846

Animal virus replication and RNAi-mediated antiviral silencing in Caenorhabditis elegans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302846

RNA interference is an antiviral defence mechanism in Caenorhabditis elegans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302846

Dissecting HIV-1 through RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302846

RNA interference as a new strategy against viral hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302846

Silencing viruses by RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302846

Small interfering RNA Inhibits Hepatitis B virus replication in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302846

Inhibition of hepatitis B virus replication in vivo by nucleoside analogues and siRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302846

Inhibition of hepatitis B virus in mice by RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302846

Activity of stabilized short interfering RNA in a mouse model of hepatitis B virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302846

Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302846

Clearance of hepatitis B virus from the liver of transgenic mice by short hairpin RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302846

Effective inhibition of HBV replication in vivo by anti-HBx short hairpin RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302846

Gene therapy progress and prospects: adenoviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302846

A pilot study of in vivo liver-directed gene transfer with an adenoviral vector in partial ornithine transcarbamylase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302846

Adeno-associated virus vectors: potential applications for cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302846

Adeno-associated virus vectors in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302846

Nonrandom transduction of recombinant adeno-associated virus vectors in mouse hepatocytes in vivo: cell cycling does not influence hepatocyte transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302846

Immune responses to adenovirus and adeno-associated virus in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302846

Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302846

Gene therapy with novel adeno-associated virus vectors substantially diminishes atherosclerosis in a murine model of familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302846

Efficacy of an adeno-associated virus 8-pseudotyped vector in glycogen storage disease type II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302846

Total correction of hemophilia A mice with canine FVIII using an AAV 8 serotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302846

Sustained correction of disease in naive and AAV2-pretreated hemophilia B dogs: AAV2/8-mediated, liver-directed gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302846

Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302846

Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302846

RNA interference-mediated control of hepatitis B virus and emergence of resistant mutant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302846

Evaluation of transcriptional efficiency of hepatitis B virus covalently closed circular DNA by reverse transcription-PCR combined with the restriction enzyme digestion method

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302846

Viral cross talk: intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302846

Protection against lethal influenza virus challenge by RNA interference in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302846

Inhibition of influenza virus production in virus-infected mice by RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302846

Inhibition of respiratory viruses by nasally administered siRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302846

Inhibition of respiratory syncytial virus infection with intranasal siRNA nanoparticles targeting the viral NS1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302846

Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302846

Utilization of transgenic mice replicating high levels of hepatitis B virus for antiviral evaluation of lamivudine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302846

Characterizing antiviral activity of adefovir dipivoxil in transgenic mice expressing hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302846

Nuclear covalently closed circular viral genomic DNA in the liver of hepatocyte nuclear factor 1 alpha-null hepatitis B virus transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302846

Unrestricted hepatocyte transduction with adeno-associated virus serotype 8 vectors in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302846

Rapid uncoating of vector genomes is the key to efficient liver transduction with pseudotyped adeno-associated virus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302846

Genomic stability of self-complementary adeno-associated virus 2 during early stages of transduction in mouse muscle in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302846

Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302846

Comparison of the ability of adeno-associated viral vectors pseudotyped with serotype 2, 5, and 8 capsid proteins to mediate efficient transduction of the liver in murine and nonhuman primate models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302846

Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302846

Clades of Adeno-associated viruses are widely disseminated in human tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302846

Short interfering RNA confers intracellular antiviral immunity in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302846

Human immunodeficiency virus type 1 escape from RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302846

A preliminary trial of lamivudine for chronic hepatitis B infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302846

inferred from DOI database lookup

7 January 2021

based on heuristic

Inhibition of hepatitis B virus replication during adenovirus and cytomegalovirus infections in transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302846

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.GT.3302846

1 reference

Dimensions Publication ID

18 September 2017

1025149738

0 references

Fatcat ID

release_rvvrwe5bd5e2nccsggn4ufqzom

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rvvrwe5bd5e2nccsggn4ufqzom

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference